A detailed history of Salem Capital Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Salem Capital Management Inc holds 16,377 shares of NVS stock, worth $1.91 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
16,377
Previous 16,577 1.21%
Holding current value
$1.91 Million
Previous $1.4 Million 11.13%
% of portfolio
0.99%
Previous 1.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 29, 2022

SELL
$74.61 - $87.26 $14,922 - $17,452
-200 Reduced 1.21%
16,377 $1.25 Million
Q2 2022

Jul 27, 2022

SELL
$80.52 - $93.75 $275,136 - $320,343
-3,417 Reduced 17.09%
16,577 $1.4 Million
Q4 2021

Jan 18, 2022

SELL
$79.7 - $88.13 $856,775 - $947,397
-10,750 Reduced 34.97%
19,994 $1.75 Million
Q3 2021

Oct 12, 2021

BUY
$81.78 - $95.14 $1.8 Million - $2.09 Million
22,000 Added 251.6%
30,744 $2.51 Million
Q2 2021

Jul 13, 2021

BUY
$85.24 - $94.15 $25,572 - $28,245
300 Added 3.55%
8,744 $798,000
Q1 2020

Apr 14, 2020

SELL
$70.67 - $99.01 $63,603 - $89,109
-900 Reduced 9.63%
8,444 $696,000
Q1 2019

Apr 15, 2019

SELL
$75.32 - $86.15 $42,103 - $48,157
-559 Reduced 5.64%
9,344 $898,000
Q4 2018

Jan 08, 2019

SELL
$73.66 - $82.02 $8,544 - $9,514
-116 Reduced 1.16%
9,903 $850,000
Q3 2018

Oct 09, 2018

BUY
$66.94 - $77.43 $16,132 - $18,660
241 Added 2.46%
10,019 $863,000
Q2 2018

Jul 09, 2018

SELL
$64.91 - $73.36 $32,584 - $36,826
-502 Reduced 4.88%
9,778 $739,000
Q1 2018

Apr 09, 2018

SELL
$70.39 - $84.15 $12,318 - $14,726
-175 Reduced 1.67%
10,280 $831,000
Q4 2017

Jan 16, 2018

BUY
$72.33 - $77.64 $12,657 - $13,587
175 Added 1.7%
10,455 $878,000
Q3 2017

Oct 10, 2017

BUY
$74.14 - $77.27 $762,159 - $794,335
10,280
10,280 $883,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $251B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Salem Capital Management Inc Portfolio

Follow Salem Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Capital Management Inc with notifications on news.